Clinical Trial Update: Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating co-transplantation of mesenchymal stem cell-derived exosomes and autologous mitochondria for patients undergoing CABG surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Myocardial Ischemia
• Myocardial Stunning

Drugs mentioned

• Mesenchymal Stem Cell-Derived Exosomes
• autologous mitochondria

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Myocardial Infarction, Myocardial Ischemia | Phase 1, Phase 2 | Status: UNKNOWN